Innate immune recognition of lipopolysaccharide by endothelial cells

Critical Care Medicine

Volumn 30, Issue 5 SUPPL., 2002, Pages

  Henneke, Philipp ^a   Golenbock, Douglas T ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Bacterial DNA; Lipopolysaccharide; Sepsis; Signal transduction; Toll like receptors

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; CYTOPLASM PROTEIN; TOLL LIKE RECEPTOR 4;

ANTIGEN RECOGNITION; CELL SURFACE; CONFERENCE PAPER; ENDOTHELIUM CELL; GRAM NEGATIVE BACTERIUM; IMMUNE RESPONSE; INFLAMMATION; POINT MUTATION; PRIORITY JOURNAL; SEPSIS; SIGNAL TRANSDUCTION;

EID: 0036245203     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200205001-00006     Document Type: Conference Paper

References (87)

1. Markers of endothelial dysfunction
2. Cytokine regulation of endothelial cell function
3. CD14 is a pattern recognition receptor
4. The immune system evolved to discriminate infectious nonself from non-infectious self
5. Recognition and plasma clearance of endotoxin by scavenger receptors
6. New scavenger receptor-like receptors for the binding of lipopolysaccharide to liver endothelial and Kupffer cells
7. CD14 contributes to the adherence of human monocytes to cytokine-stimulated endothelial cells
8. Endotoxin alters arachidonate metabolism in pulmonary endothelial cells
9. Binding of bacterial peptidoglycan to CD14
10. Specifc binding of soluble peptidoglycan and muramyIdipeptide to CD14 on human monocytes
11. Cell-free pool of CD14 mediates activation of transcription factor NP-kappa B by lipopolysaccharide in human endothelial cells
12. Soluble CD14 participates in the response of cells to lipopolysaccharide
13. LPS-binding proteins and receptors
14. Extolling the diversity of bacterial endotoxins
15. Toll-like receptors in the induction of the innate immune response
16. Innate immunity
17. A family of human receptors structurally related to Drosophila Toll
18. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene
19. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4)
20. Cutting edge: Cells that carry a null allele for Toll-like receptor 2 are capable of responding to endotoxin
21. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the LPS gene product
22. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction
23. Moesin functions as a lipopolysaccharide receptor on human monocytes
24. A CD14-independent LPS receptor cluster
25. Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages
26. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism
27. MD-2 and TLR4 N-linked glycosylations are important for a functional lipopolysaccharide receptor
28. MD-2 binds to bacterial lipopolysaccharide
29. Signaling mechanisms in the antimicrobial host defense of Drosophila
30. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide
31. Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation
32. Lipopolysaccharide induces physical proximity between CD14 and Toll-like receptor 4 (TLR4) prior to nuclear translocation of NP-kappaB
33. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2
34. Cutting edge: Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2
35. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4
36. Molecular genetic analysis of an endotoxin non-responder mutant cell line: A point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling
37. Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4
38. N-linked glycosylations at asn(26) and asn(114) of human md-2 are required for Toll-like receptor 4-mediated activation of NP-kappaB by lipopolysaccharide
39. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses
40. E5531, a synthetic non-toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharide
41. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide
42. MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components
43. Novel engagement of CD14 and multiple Toll-like receptors by group B streptococci
44. Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells: Differential expression of TLR-4 and TLR-2 in endothelial cells
45. Cooperation of Toll-Like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: Role of Toll-Interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling
46. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products
47. Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis
48. Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: Role of NF-kappa B activation
49. Dominant and recessive mutations define functional domains of Toll, a transmembrane protein required for dorsal-ventral polarity in the Drosophila embryo
50. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains
51. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
52. TIRAP: How Toll receptors fraternize
53. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors
54. Discrimination of bacterial lipoproteins by Toll-like receptor 6
55. CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide
56. CD11/CD18 and CD14 share a common lipid A signaling pathway
57. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3
58. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
59. A Toll-like receptor recognizes bacterial DNA
60. Recognition of CpG DNA is mediated by signaling pathways dependent on the adaptor protein MyD88
61. Unresponsiveness of MyD88-deficient mice to endotoxin
62. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection
63. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens
64. Cutting edge: Functional characterization of the effect of the C3H/HeJ defect in mice that lack an Lpsn gene: In vivo evidence for a dominant negative mutation
65. TIRAP: An adapter molecule in the Toll signaling pathway
66. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction
67. Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor
68. Negative regulation of Toll-like receptor-mediated signaling by Tollip
69. Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway
70. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha
71. Involvement of phosphoinositide 3-kinases in neutrophil activation and the development of acute lung injury
72. Construction of a lipopolysaccharide reporter cell line and its use in identifying mutants defective in endotoxin, but not TNF-alpha, signal transduction
73. IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family
74. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling
75. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways
76. IL-1 receptor-associated kinase modulates host responsiveness to endotoxin
77. TAK1 is a ubiquitin-dependent kinase of MKK and IKK
78. ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway
79. The transcription factor NF-kappa B and the regulation of vascular cell function
80. Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B
81. Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-kappa B
82. Protective genes expressed in endothelial cells: A regulatory response to injury
83. Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB
84. CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri
85. Human Nod1 confers responsiveness to bacterial lipopolysaccharides
86. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
87. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease